Disability News and Research

RSS

Integrated care reduces hospital visits for adults with disabilities

University of Cincinnati and Ohio State University researchers have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not.

5 Jun 2026

Grant fuels research into SYNGAP1-linked behavioral abnormalities

CURE SYNGAP1 501(c)(3) is pleased to announce a $130,000 grant to Dr. Helen Willsey and Dr. David Kastner at the University of California, San Francisco (UCSF).

5 Jun 2026

American Heart Association introduces new certification for stroke coordinators

Stroke remains a leading cause of death and disability in the United States, underscoring the need for effective, coordinated evidence–based care across hospitals and health systems.

5 Jun 2026

Major trials show finerenone preserves kidney function beyond diabetes

A series of major studies has shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves survival across a much broader range of patients with chronic kidney disease (CKD) than it is currently recommended for.

5 Jun 2026

Partial social inclusion may harm immigrants' long-term health

There is a well-documented puzzle in social epidemiology: immigrants have better health than the native-born when they first arrive, but they lose this advantage at older ages.

4 Jun 2026

Common hypertension drugs tied to worse kidney outcomes in T2D patients

New research presented at the 63rd ERA Congress suggests that a widely used class of blood pressure medications may be associated with poorer kidney outcomes in people with type 2 diabetes (T2D), even among patients already receiving modern kidney-protective treatments.

4 Jun 2026

Scientists merge massive databases to map early warning signs of depression

The Wellcome Trust is funding the FUTURE-D research consortium with nearly €6 million. The consortium is coordinated by Universitätsmedizin Frankfurt.

4 Jun 2026

Dietary exposure to toxic metals causes over one million annual deaths

Children aged less than five years face almost three times the risk of illness from unsafe food than older children and adults, according to new estimates released today by the World Health Organization (WHO).

4 Jun 2026

CAR-T cell therapy shows promise for treating rheumatoid arthritis

Current therapies for rheumatoid arthritis rely on sustained immunosuppression rather than restoration of immune tolerance, with off-drug remission remaining rare.

3 Jun 2026

New PET imaging approach quantifies synaptic pathology in multiple sclerosis

A new PET imaging approach that measures synaptic density in the spinal cord provides a quantitative way to assess the brain's functional wiring in patients with multiple sclerosis.

2 Jun 2026

Tailored meal programs reduce hospitalizations for chronic disease patients

At least a dozen U.S. states are rolling out medically tailored meals in pilot projects through Medicaid, the federal–state health insurance program serving 71 million Americans who qualify based on income or disability status.

2 Jun 2026

Shopping data reveals hidden period pain disparities in England

The study highlights how shopping behavior reflects menstrual pain prevalence, revealing inequalities in health management across income levels.

2 Jun 2026

Researchers develop real time sensor system for early detection of ICU brain infections

A research team led by the University of Waterloo has created a new monitoring system to save lives and significantly reduce health-care costs in brain-injury cases through the early detection of infections in intensive care units.

2 Jun 2026

AI is mapping health stigma faster than it is fixing it

This scoping review of 70 studies found that AI is used mainly to detect and measure health-related stigma, rather than to reduce it. Evidence that AI can reduce stigma remains early, limited, and concentrated in mental health conversational-agent studies.

1 Jun 2026

Higher-dose ocrelizumab depletes more B cells but does not slow MS progression

Higher-dose ocrelizumab produced greater peripheral B-cell depletion than the approved 600 mg regimen in two phase 3b trials of relapsing and primary progressive multiple sclerosis. However, the higher doses did not significantly delay disability progression, supporting the 600 mg dose as the current standard regimen with a favorable benefit-risk profile.

31 May 2026

New protocol screens clinical research participants for prior radiation exposure

A new study highlights a critical gap: most clinical research studies that use imaging techniques such as amyloid positron emission tomography (PET) scans do not account for the radiation participants have already received from prior medical procedures.

29 May 2026

Sociological shifts change expectations and behaviors of modern patients

Whereas patients in the past were expected to be patient, grateful, passive and docile - many of today's patients are assertive, demanding, impatient and insistent. So, what has happened?

29 May 2026

Ocrelizumab slows disability progression in advanced progressive multiple sclerosis

A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab – a medication already prescribed to some patients with MS – significantly slows disability progression in people with primary progressive multiple sclerosis (PPMS), including older patients and those with more advanced disease who are wheelchair users.

28 May 2026

Major trial compares surgical approaches for treating Chiari malformation and syringomyelia

A nationwide study has shed new light on how to most effectively and safely treat Chiari malformation and syringomyelia, rare neurological diseases that impact both children and young adults.

27 May 2026

Adults with developmental disabilities or cerebral palsy face earlier fall injury risks

Falls are a common cause of injury, especially for adults over age 65. But adults with intellectual and/or developmental disabilities or cerebral palsy may also be at higher risk.

26 May 2026